Conquering IBS in women: the clinician's pursuit of optimum management strategies.
Peura
David A
DA
University of Virginia Health Sciences Center, Charlottesville, VA, USA.
Rose
Suzanne
S
Miller
Howard A
HA
D000527:Alprostadil / Q000031:analogs & derivatives / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000930:Antidiarrheals / Q000627:therapeutic use; D003142:Communication; D015897:Comorbidity; D005260:Female; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D000068238:Lubiprostone; D010817:Physician-Patient Relations; D011092:Polyethylene Glycols / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D000527:Alprostadil; D000900:Anti-Bacterial Agents; D000930:Antidiarrheals; D000068238:Lubiprostone; D011092:Polyethylene Glycols; D017366:Serotonin Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors